Literature DB >> 10534732

Human herpesviruses 6 and 7 as potential pathogens after liver transplant: prospective comparison with the effect of cytomegalovirus.

P D Griffiths1, M Ait-Khaled, C P Bearcroft, D A Clark, A Quaglia, S E Davies, A K Burroughs, K Rolles, I M Kidd, S N Knight, S M Noibi, A V Cope, A N Phillips, V C Emery.   

Abstract

Because cytomegalovirus (CMV) is an important opportunistic infection after liver transplant, we conducted a prospective study to see if the same applied to human herpesviruses (HHV)-6 and -7. We used polymerase chain reaction (PCR) methods optimised to detect active, not latent, infection and studied patients not receiving antiviral prophylaxis for CMV. Post-transplant, 536 blood samples were tested by PCR (median 7; range 4-50). Active infection with CMV was detected in 28/60 (47%), HHV-6 in 19/60 (32%), and HHV-7 in 29/60 (48%) of patients. The PCR-positive samples were tested by quantitative-competitive PCR to measure the virus load of each betaherpesvirus. The median peak virus load for CMV was significantly greater than that for HHV-6 or HHV-7. Detailed clinicopathological analyses for the whole population showed that CMV and HHV-6 were each significantly associated with biopsy-proven graft rejection. Individual case histories suggested that HHV-6 and HHV-7 may be the cause of some episodes of hepatitis and pyrexia. It is concluded that HHV-6 is a previously unrecognized contributor to the morbidity of liver transplantation, that HHV-7 may also be important and that both viruses should be included in the differential diagnosis of graft dysfunction. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10534732     DOI: 10.1002/(sici)1096-9071(199912)59:4<496::aid-jmv12>3.0.co;2-u

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  24 in total

1.  Recent Advances in the Management of Infections in Liver Transplant Recipients.

Authors:  Nina Singh
Journal:  Curr Infect Dis Rep       Date:  2001-04       Impact factor: 3.725

Review 2.  Herpesvirus infections in organ transplant recipients.

Authors:  Frank J Jenkins; David T Rowe; Charles R Rinaldo
Journal:  Clin Diagn Lab Immunol       Date:  2003-01

3.  Predictive value of quantitative PCR-based viral burden analysis for eight human herpesviruses in pediatric solid organ transplant patients.

Authors:  X Bai; B B Rogers; P C Harkins; J Sommerauer; R Squires; K Rotondo; A Quan; D B Dawson; R H Scheuermann
Journal:  J Mol Diagn       Date:  2000-11       Impact factor: 5.568

Review 4.  Cytomegalovirus and the aging population.

Authors:  V C Emery
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

Review 5.  Update on human herpesvirus 6 biology, clinical features, and therapy.

Authors:  Leen De Bolle; Lieve Naesens; Erik De Clercq
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

6.  Impact of human herpes virus 6 in liver transplantation.

Authors:  Raymund R Razonable; Irmeli Lautenschlager
Journal:  World J Hepatol       Date:  2010-09-27

Review 7.  Human herpesvirus 6 infections after liver transplantation.

Authors:  Rima Camille Abdel Massih; Raymund R Razonable
Journal:  World J Gastroenterol       Date:  2009-06-07       Impact factor: 5.742

8.  Detection of human herpesvirus 7 DNA by loop-mediated isothermal amplification.

Authors:  Tetsushi Yoshikawa; Masaru Ihira; Shiho Akimoto; Chie Usui; Fumi Miyake; Sadao Suga; Yoshihiko Enomoto; Ryota Suzuki; Yukihiro Nishiyama; Yoshizo Asano
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

9.  Persistent human herpesvirus-6 infection in patients with an inherited form of the virus.

Authors:  Shara N Pantry; Maria M Medveczky; Jesse H Arbuckle; Janos Luka; Jose G Montoya; Jianhong Hu; Rolf Renne; Daniel Peterson; Joshua C Pritchett; Dharam V Ablashi; Peter G Medveczky
Journal:  J Med Virol       Date:  2013-07-25       Impact factor: 2.327

Review 10.  Cytomegalovirus infection in critically ill patients: a systematic review.

Authors:  Ryosuke Osawa; Nina Singh
Journal:  Crit Care       Date:  2009-05-14       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.